127 related articles for article (PubMed ID: 24607205)
1. Galactosylated polymeric carriers for liver targeting of sorafenib.
Craparo EF; Sardo C; Serio R; Zizzo MG; Bondì ML; Giammona G; Cavallaro G
Int J Pharm; 2014 May; 466(1-2):172-80. PubMed ID: 24607205
[TBL] [Abstract][Full Text] [Related]
2. Galactosylated micelles for a ribavirin prodrug targeting to hepatocytes.
Craparo EF; Triolo D; Pitarresi G; Giammona G; Cavallaro G
Biomacromolecules; 2013 Jun; 14(6):1838-49. PubMed ID: 23621358
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticles of a polyaspartamide-based brush copolymer for modified release of sorafenib: In vitro and in vivo evaluation.
Cervello M; Pitarresi G; Volpe AB; Porsio B; Balasus D; Emma MR; Azzolina A; Puleio R; Loria GR; Puleo S; Giammona G
J Control Release; 2017 Nov; 266():47-56. PubMed ID: 28917533
[TBL] [Abstract][Full Text] [Related]
4. Novel composed galactosylated nanodevices containing a ribavirin prodrug as hepatic cell-targeted carriers for HCV treatment.
Craparo EF; Teresi G; Licciardi M; Bondí ML; Cavallaro G
J Biomed Nanotechnol; 2013 Jun; 9(6):1107-22. PubMed ID: 23858977
[TBL] [Abstract][Full Text] [Related]
5. Targeted therapy for human hepatic carcinoma cells using folate-functionalized polymeric micelles loaded with superparamagnetic iron oxide and sorafenib in vitro.
Zhang L; Gong F; Zhang F; Ma J; Zhang P; Shen J
Int J Nanomedicine; 2013; 8():1517-24. PubMed ID: 23620667
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional pH-sensitive polymeric nanoparticles for theranostics evaluated experimentally in cancer.
Liu Y; Feng L; Liu T; Zhang L; Yao Y; Yu D; Wang L; Zhang N
Nanoscale; 2014 Mar; 6(6):3231-42. PubMed ID: 24500240
[TBL] [Abstract][Full Text] [Related]
7. Polymeric drug delivery micelle-like nanocarriers for pulmonary administration of beclomethasone dipropionate.
Triolo D; Craparo EF; Porsio B; Fiorica C; Giammona G; Cavallaro G
Colloids Surf B Biointerfaces; 2017 Mar; 151():206-214. PubMed ID: 28013164
[TBL] [Abstract][Full Text] [Related]
8. Biocompatible polymeric micelles with polysorbate 80 for use in brain targeting.
Craparo EF; Ognibene MC; Casaletto MP; Pitarresi G; Teresi G; Giammona G
Nanotechnology; 2008 Dec; 19(48):485603. PubMed ID: 21836304
[TBL] [Abstract][Full Text] [Related]
9. Galangin loaded galactosylated pluronic F68 polymeric micelles for liver targeting.
Patil S; Ujalambkar V; Rathore A; Rojatkar S; Pokharkar V
Biomed Pharmacother; 2019 Apr; 112():108691. PubMed ID: 30798131
[TBL] [Abstract][Full Text] [Related]
10. Galactosylated α,β-poly[(2-hydroxyethyl)-L-aspartamide]-bound doxorubicin: improved antitumor activity against hepatocellular carcinoma with reduced hepatotoxicity.
Cheng X; Gao F; Xiang J; Jiang X; Chen J; Zhang J
Anticancer Drugs; 2011 Feb; 22(2):136-47. PubMed ID: 20966743
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic study of conventional sorafenib chemoembolization in a rabbit VX2 liver tumor model.
Parvinian A; Casadaban LC; Hauck ZZ; van Breemen RB; Gaba RC
Diagn Interv Radiol; 2015; 21(3):235-40. PubMed ID: 25835078
[TBL] [Abstract][Full Text] [Related]
12. Fabrication of poly (butadiene-block-ethylene oxide) based amphiphilic polymersomes: An approach for improved oral pharmacokinetics of Sorafenib.
Khan MA; Ali S; Venkatraman SS; Sohail MF; Ovais M; Raza A
Int J Pharm; 2018 May; 542(1-2):196-204. PubMed ID: 29551745
[TBL] [Abstract][Full Text] [Related]
13. Interaction between drug loaded polyaspartamide-polylactide-polysorbate based micelles and cell membrane models: a calorimetric study.
Sarpietro MG; Pitarresi G; Ottimo S; Giuffrida MC; Ognibene MC; Fiorica C; Giammona G; Castelli F
Mol Pharm; 2011 Jun; 8(3):642-50. PubMed ID: 21517047
[TBL] [Abstract][Full Text] [Related]
14. Galactosylated fluorescent labeled micelles as a liver targeting drug carrier.
Wu DQ; Lu B; Chang C; Chen CS; Wang T; Zhang YY; Cheng SX; Jiang XJ; Zhang XZ; Zhuo RX
Biomaterials; 2009 Mar; 30(7):1363-71. PubMed ID: 19100617
[TBL] [Abstract][Full Text] [Related]
15. Phospholipid-polyaspartamide micelles for pulmonary delivery of corticosteroids.
Craparo EF; Teresi G; Bondi' ML; Licciardi M; Cavallaro G
Int J Pharm; 2011 Mar; 406(1-2):135-44. PubMed ID: 21185363
[TBL] [Abstract][Full Text] [Related]
16. Galactose-decorated cross-linked biodegradable poly(ethylene glycol)-b-poly(ε-caprolactone) block copolymer micelles for enhanced hepatoma-targeting delivery of paclitaxel.
Yang R; Meng F; Ma S; Huang F; Liu H; Zhong Z
Biomacromolecules; 2011 Aug; 12(8):3047-55. PubMed ID: 21726090
[TBL] [Abstract][Full Text] [Related]
17. Folate-decorated anticancer drug and magnetic nanoparticles encapsulated polymeric carrier for liver cancer therapeutics.
Li YJ; Dong M; Kong FM; Zhou JP
Int J Pharm; 2015 Jul; 489(1-2):83-90. PubMed ID: 25888801
[TBL] [Abstract][Full Text] [Related]
18. The use of lipid-coated nanodiamond to improve bioavailability and efficacy of sorafenib in resisting metastasis of gastric cancer.
Zhang Z; Niu B; Chen J; He X; Bao X; Zhu J; Yu H; Li Y
Biomaterials; 2014 May; 35(15):4565-72. PubMed ID: 24602567
[TBL] [Abstract][Full Text] [Related]
19. Amphiphilic polyaspartamide copolymer-based micelles for rivastigmine delivery to neuronal cells.
Scialabba C; Rocco F; Licciardi M; Pitarresi G; Ceruti M; Giammona G
Drug Deliv; 2012 Aug; 19(6):307-16. PubMed ID: 22931301
[TBL] [Abstract][Full Text] [Related]
20. Lipid nanocarriers containing sorafenib inhibit colonies formation in human hepatocarcinoma cells.
Bondì ML; Botto C; Amore E; Emma MR; Augello G; Craparo EF; Cervello M
Int J Pharm; 2015 Sep; 493(1-2):75-85. PubMed ID: 26211902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
